2020/12/11

(Correction) Notice Regarding Partial Correction of the “Oncolys and ASAHI INTECC CO., LTD. Announces Conclusion of Capital and Business Alliance”

Oncolys BioPharma (headquartered in Minato-ku, Tokyo; Yasuo Urata, Representative CEO; hereinafter “Oncolys”) and Asahi Intecc Co., Ltd. (headquartered in Seto-city, Aichi Prefecture; Masahiko Miyata, President & CEO; hereinafter “Asahi Intecc”) hereby notifies that, some portions of the “Oncolys and ASAHI INTECC CO., LTD. Announces Conclusion of Capital and Business Alliance” which were announced on December 10, 2020 should be corrected as follows.

Click here for details.